These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 28188630)

  • 1. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
    Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
    J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia.
    Hata T; Suenaga M; Marchionni L; Macgregor-Das A; Yu J; Shindo K; Tamura K; Hruban RH; Goggins M
    Am J Pathol; 2018 Jul; 188(7):1723-1733. PubMed ID: 29684357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.
    Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH
    Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.
    Murphy SJ; Hart SN; Lima JF; Kipp BR; Klebig M; Winters JL; Szabo C; Zhang L; Eckloff BW; Petersen GM; Scherer SE; Gibbs RA; McWilliams RR; Vasmatzis G; Couch FJ
    Gastroenterology; 2013 Nov; 145(5):1098-1109.e1. PubMed ID: 23912084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of pancreatic intraepithelial neoplasia.
    Feldmann G; Beaty R; Hruban RH; Maitra A
    J Hepatobiliary Pancreat Surg; 2007; 14(3):224-32. PubMed ID: 17520196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characteristics of Pancreatic Ductal Adenocarcinomas with High-Grade Pancreatic Intraepithelial Neoplasia (PanIN) Are Different from Those without High-Grade PanIN.
    Miyazaki T; Ohishi Y; Miyasaka Y; Oda Y; Aishima S; Ozono K; Abe A; Nagai E; Nakamura M; Oda Y
    Pathobiology; 2017; 84(4):192-201. PubMed ID: 28291966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
    Masetti M; Acquaviva G; Visani M; Tallini G; Fornelli A; Ragazzi M; Vasuri F; Grifoni D; Di Giacomo S; Fiorino S; Lombardi R; Tuminati D; Ravaioli M; Fabbri C; Bacchi-Reggiani ML; Pession A; Jovine E; de Biase D
    Cancer Biomark; 2018 Feb; 21(2):323-334. PubMed ID: 29103024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.
    Goggins M; Hruban RH; Kern SE
    Am J Pathol; 2000 May; 156(5):1767-71. PubMed ID: 10793087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
    Rosty C; Geradts J; Sato N; Wilentz RE; Roberts H; Sohn T; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Am J Surg Pathol; 2003 Dec; 27(12):1495-501. PubMed ID: 14657708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
    Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
    Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer.
    Yokode M; Akita M; Fujikura K; Kim MJ; Morinaga Y; Yoshikawa S; Terada T; Matsukiyo H; Tajiri T; Abe-Suzuki S; Itoh T; Hong SM; Zen Y
    Histopathology; 2018 Aug; 73(2):247-258. PubMed ID: 29660164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.
    Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA
    Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells.
    Lee J; Snyder ER; Liu Y; Gu X; Wang J; Flowers BM; Kim YJ; Park S; Szot GL; Hruban RH; Longacre TA; Kim SK
    Nat Commun; 2017 Mar; 8():14686. PubMed ID: 28272465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.